Consumer

By Jonah Comstock January 11, 2019
The Embrace2, a seizure monitoring wearable from Boston and Milan-based Embrace, has received an updated FDA clearance that allows it to be used by children ages six and up — the first such device to receive clearance for pediatric use. "The fact that this is the first clearance of its kind in epilepsy highlights how difficult it is to get robust results with pediatric patients in a clinical...

Photo: Dr. James Creeden, Global Medical Director of Foundation Medicine​. Credit: Foundation Medicine.

By Dean Koh January 10, 2019
Launched in 2010 with a $25 million Series A financing led by Third Rock Ventures, Foundation Medicine released its first commercial assay called FoundationOne in 2012. The company develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumours, hematologic malignancies, and sarcomas. In December 2017, the company’s assay FoundationOne...
By Dave Muoio January 10, 2019
The FDA has granted 510(k) clearance to an over-the-counter handheld electronic device for treating hay fever sinus pains, according to an announcement from its manufacturer. Tivic Health Systems’ ClearUP Sinus Pain Relief device is non-invasive and does not rely on a pharmacological component. Instead, the single-button device is run along the skin of the user's cheek, nose and brow, where it...
By Dave Muoio January 10, 2019
This week at CES 2019, Royal Philips unveiled a new app platform that links the company’s senior care products into a single digital ecosystem for family caretakers. Called Philips Cares, the app includes a range of features to track and manage a senior’s care, such as reminders, scheduling tools and access to emergency services. “We’ve been in the business for more than four decades now. We...
By Laura Lovett January 8, 2019
This morning, consumer genomic giant 23andMe revealed that it is teaming up with Lark Health, an AI platform that helps users manage chronic conditions, on a new initiative that will integrate a user’s 23andMe genetic information into Lark’s Wellness Program and Diabetes Prevention Program. The idea is that Lark’s AI weight loss and wellness coach will be able to access a user’s genetic...
By Dave Muoio January 8, 2019
VRHealth, a tech company focused on virtual reality products for various healthcare implementations, has launched a new set of apps that look to better facilitate remote monitoring and family caregiving. Developed in collaboration with AARP’s Innovation Lab and announced at CES 2019, the app-based platform employs in-home VR for a range of different use cases and capabilities, according to the...
By Laura Lovett January 7, 2019
CES is upon us and some of the biggest digital health announcements of the year are beginning to emerge. Babyforyou.net.ua is keeping a running list of the technology being announced in Las Vegas this week, and we will update this as the week goes on.  RxPense is a smart medication dispenser. The technology is aimed at helping seniors and elder care facilities manage therapies and adherence. The...

Ping An Good Doctor's first One-minute Clinic in Wuzhen, outside of Shanghai. Credit: Ping An Good Doctor.

By Dean Koh January 7, 2019
Last year, Ping An Good Doctor, a one-stop healthcare ecosystem platform from China, piloted unstaffed clinics that employ artificial intelligence called “One-minute Clinics” in the Wuzhen Scenic Area outside of Shanghai, which connect patients with a clinician on Ping An Good Doctor’s in-house medical team. Just last week, the company announced that it had placed its One-minute Clinics across 8...
By Laura Lovett January 3, 2019
Just in time for those New Year’s resolutions, Lifesum, a Swedish health tracking app, will now be available to Google Assistant users. This integration will allow users to keep a record of their meals, water consumption and weight by talking to their Google Assistant.  Users can access the system by saying “Hey Google, talk to Lifesum,” according to a press release. Once opened the user can tell...
By Dave Muoio January 3, 2019
Sugar.IQ — the digital diabetes assistant for Guardian Connect system users that is jointly supported by Medtronic and IBM Watson — has a new feature that uses artificial intelligence to predict future low glucose events. Called IQcast, the feature tells users whether they have a low, medium or high chance of dropping below the target blood glucose range within the next one to four hours. These...